Stephen C. Bergmeier

Stephen C. Bergmeier is a Professor in the Department of Chemistry and Biochemistry within the College of Arts and Sciences at Ohio University. His research bridges synthetic organic chemistry and biological applications, with a focus on developing novel therapeutic strategies for cancer and infectious diseases.

Research Interests: His work spans three primary areas: (1) Design of glucose uptake inhibitors as anticancer agents, targeting cancer metabolism; (2) Development of small molecules that modulate RNA transcription via T-box riboswitches, offering new antibacterial strategies; and (3) Synthetic methodology involving strained heterocycles like aziridines for constructing complex nitrogen-containing ring systems. These projects highlight the synergy between method development and drug discovery.

Publication Trends: His recent publications (2010–2017) reflect a consistent focus on heterocyclic synthesis, mechanism-driven drug design, and chemical biology. The articles reveal an interdisciplinary approach combining organic synthesis, molecular modeling, and biological evaluation, particularly in targeting metabolic pathways and RNA structures in disease.

• Scientific Awards:

No awards are listed in the provided text.

Advising and Grants: While specific students and grant funding are not mentioned, Dr. Bergmeier leads an active research group with collaborative projects involving Prof. X. Chen (cancer metabolism) and Prof. J. V. Hines (RNA biology), suggesting external funding and mentorship of graduate students and researchers.

Labs and Teams: His research is conducted at Ohio University’s Athens Campus in the Chemistry and Biochemistry department, likely involving a research group focused on synthetic and medicinal chemistry. The work is collaborative and integrates organic synthesis with biochemical and cellular assays.